Principal Regulatory Program Director
Roche
Basel, Basel-Stadt, Switzerland
Andreas Emmendoerffer, MD, PhD, Principle Regulatory Program Director at Roche Pharma Ltd, Switzerland.
Senior Regulatory Affairs professional with strong background in Medicinal Products, Combination Products, Medical Devices, Regenerative Medicine (Advanced Therapy Medicinal Products) and Quality Assurance. Medical Doctor with significant expertise in Immunology, Immunotoxicology, In vitro Toxicology and Inflammatory Diseases/ Oncology. More than 25 years of international experience in regulatory affairs and quality assurance
including pharma/ cell therapeutics and medical devices/ combination products. More than 15 years of experience in Applied Research and Contract research. More than 10 years hands-on experience and profound entrepreneurial background in business development of biotech/medtech start-ups. Direct leadership experience in international internal and external teams.
Active in several industry organisations like EFPIA, RAPS, DIA and ISPE.
From Parallel Pathways to Collaborative workstreams: The Evolving EMA–FDA Regulatory Partnership
Thursday, May 7, 2026
08:30 - 09:30 WEST
Plenary Session: Simplification vs. Innovation in Regulatory Affairs: Which Drives Progress?
Friday, May 8, 2026
08:30 - 10:00 WEST